Price Forecast:

Bullish Case: Increased consumer interest in health and wellness, alongside strategic marketing initiatives, could drive MED sales higher, potentially lifting the stock price above $25 by mid-2025.

Bearish Case: If operational challenges persist and market volatility increases, MED could face significant downturn pressures, possibly declining to the $15 range in 2025.

Potential Outcomes:

• 1. Recovery in consumer interest leading to a 30% price rise by Q2 2025 (45%).
• 2. Ongoing operational inefficiencies cause a price drop to $15 (35%).
• 3. Stabilization with minimal price changes around current levels (20%).

Trading Oracle: Given the high implied volatility and near-term bearish sentiment, consider a bearish credit spread by selling December 2024 $20 calls and buying $25 calls. This strategy exploits high premiums, targeting a high probability of profit (>75%) without substantial capital at risk, ideal for current market conditions.

December 10, 2024